Brown Brothers Harriman & Co’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-288
| Closed | -$3.33K | – | 1846 |
|
|
2025
Q3 | $3.33K | Buy |
288
+287
| +28,700% | +$3.36K | ﹤0.01% | 1502 |
|
|
2025
Q2 | $12 | Hold |
1
| – | – | ﹤0.01% | 1545 |
|
|
2025
Q1 | $14 | Sell |
1
-24
| -96% | -$375 | ﹤0.01% | 1302 |
|
|
2024
Q4 | $398 | Buy |
+25
| New | +$495 | ﹤0.01% | 1415 |
|
|
2024
Q2 | – | Sell |
-8
| Closed | -$159 | – | 1155 |
|
|
2024
Q1 | $159 | Sell |
8
-1,897
| -100% | -$36.7K | ﹤0.01% | 1149 |
|
|
2023
Q4 | $42.7K | Hold |
1,905
| – | – | ﹤0.01% | 748 |
|
|
2023
Q3 | $38.5K | Buy |
1,905
+1,897
| +23,713% | +$43K | ﹤0.01% | 744 |
|
|
2023
Q2 | $204 | Sell |
8
-116
| -94% | -$3.06K | ﹤0.01% | 1192 |
|
|
2023
Q1 | $3.69K | Buy |
124
+116
| +1,450% | +$3.37K | ﹤0.01% | 1095 |
|
|
2022
Q4 | $216 | Sell |
8
-393
| -98% | -$9.61K | ﹤0.01% | 1219 |
|
|
2022
Q3 | $9K | Buy |
401
+393
| +4,913% | +$10.3K | ﹤0.01% | 1158 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1300 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1258 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1157 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1153 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q1 | $0 | Sell |
8
-29
| -78% | -$1.36K | ﹤0.01% | 1105 |
|
|
2020
Q4 | $2K | Buy |
+37
| New | +$1.54K | ﹤0.01% | 1015 |
|
|
2020
Q2 | – | Sell |
-37
| Closed | -$1K | – | 989 |
|
|
2020
Q1 | $1K | Buy |
+37
| New | +$1.1K | ﹤0.01% | 978 |
|
|
2019
Q4 | – | Sell |
-49
| Closed | -$2K | – | 1116 |
|
|
2019
Q3 | $2K | Buy |
49
+24
| +96% | +$916 | ﹤0.01% | 1065 |
|
|
2019
Q2 | $1K | Sell |
25
-108
| -81% | -$4.62K | ﹤0.01% | 990 |
|
|
2019
Q1 | $6K | Sell |
133
-398
| -75% | -$17.8K | ﹤0.01% | 886 |
|
|
2018
Q4 | $24K | Hold |
531
| – | – | ﹤0.01% | 609 |
|
|
2018
Q3 | $36K | Buy |
531
+97
| +22% | +$6.24K | ﹤0.01% | 555 |
|
|
2018
Q2 | $25K | Sell |
434
-575
| -57% | -$30.4K | ﹤0.01% | 564 |
|
|
2018
Q1 | $46K | Hold |
1,009
| – | – | ﹤0.01% | 485 |
|
|
2017
Q4 | $47K | Sell |
1,009
-37
| -4% | -$1.7K | ﹤0.01% | 518 |
|
|
2017
Q3 | $47K | Hold |
1,046
| – | – | ﹤0.01% | 485 |
|
|
2017
Q2 | $41K | Hold |
1,046
| – | – | ﹤0.01% | 502 |
|
|
2017
Q1 | $40K | Hold |
1,046
| – | – | ﹤0.01% | 515 |
|
|
2016
Q4 | $39K | Sell |
1,046
-62
| -6% | -$2.22K | ﹤0.01% | 519 |
|
|
2016
Q3 | $38K | Buy |
1,108
+62
| +6% | +$2.17K | ﹤0.01% | 468 |
|
|
2016
Q2 | $34K | Sell |
1,046
-1,465
| -58% | -$44.9K | ﹤0.01% | 496 |
|
|
2016
Q1 | $72K | Sell |
2,511
-480
| -16% | -$12.8K | ﹤0.01% | 399 |
|
|
2015
Q4 | $100K | Sell |
2,991
-435
| -13% | -$13.5K | ﹤0.01% | 391 |
|
|
2015
Q3 | $97K | Sell |
3,426
-337
| -9% | -$11.8K | ﹤0.01% | 414 |
|
|
2015
Q2 | $152K | Sell |
3,763
-271
| -7% | -$12.2K | ﹤0.01% | 366 |
|
|
2015
Q1 | $198K | Sell |
4,034
-1,072
| -21% | -$49.7K | ﹤0.01% | 339 |
|
|
2014
Q4 | $232K | Buy |
+5,106
| New | +$201K | ﹤0.01% | 333 |
|
Other funds holding AVNS
AC
Brown Brothers Harriman & Co's AVNS Position: Q4 2025 in Review
Brown Brothers Harriman & Co sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 288 shares — an estimated $3.33K sold.
Brown Brothers Harriman & Co first reported a position in AVNS in Q4 2014 and held it in 39 quarters. The position peaked at $232K in Q4 2014. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.
- Brown Brothers Harriman & Co reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 288 Avanos Medical shares in Q4 2025, an estimated $3.33K.
- Brown Brothers Harriman & Co first reported a position in Avanos Medical in Q4 2014 and held it in 39 quarters.
- Brown Brothers Harriman & Co's Avanos Medical position peaked at $232K in Q4 2014.
- 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.
Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.